ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Federal Hospitals Should Share Radiotherapy Facilitates: GAO

February 16, 1979

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983